VVViktor Robertovich Veber

Viktor Robertovich Veber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Viktor Robertovich Veber has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Influence of sex, age, and female reproductive function on cardiac remodeling and the effects of renin-angiotensin-aldosterone system blockers

    by Viktor R. Weber, Veronika A. Pavlova, Svetlana V. Zhmailova, Marina M. Mamontova, Irina V. Prozorova

    BACKGROUND: Arterial hypertension (AH) has gender and age-related features of its course, while current guidelines do not differentiate the therapeutic approach depending on these factors. The influence of sex and menopausal status on the effectiveness of renin-angiotensin-aldosterone system (RAAS) blockers in achieving regression of left ventricular (LV) remodeling has been insufficiently studied, which determines the relevance of the present study. AIM: To study the effect of RAAS-blocking drugs (the angiotensin-converting enzyme inhibitor perindopril and the angiotensin II receptor blocker valsartan) on LV remodeling parameters, renin and aldosterone levels in individuals of different ages, sexes, and also in postmenopausal women. METHODS: The study included 168 patients with grade 2 hypertension (60 men and 108 women, aged 25–70 years). An analysis of structural and geometric parameters of the LV (echocardiography) and concentrations of renin and aldosterone (enzyme immunoassay) was performed depending on sex, age, and the presence of postmenopause. The dynamics of the parameters were assessed after 6 months of therapy in patients who achieved target blood pressure while taking perindopril (4 mg/day) or valsartan (80 mg/day). RESULTS: In patients older than 60 years, a significant increase in left ventricular myocardial mass index (LVMMI) was revealed (p 0.05), predominantly in the hyperreninemic type of hypertension. In postmenopausal women, an increase in LVMMI, left ventricular relative wall thickness, and renin concentration was registered (p 0.05) compared with premenopausal women, while pathological types of remodeling reached 63.6%. During therapy, the greatest regression of left ventricular hypertrophy was observed in middle-aged patients and in those with an initially high renin level. In early postmenopause, valsartan demonstrated a statistically significant advantage over perindopril in reducing LVMMI (p = 0.028) and left ventricular relative wall thickness (p = 0.018), and also achieved normalization of renin levels in 100% of patients. CONCLUSION: Age and sex of patients with hypertension, as well as menopausal status in women, significantly affect the severity of LV remodeling. Therapy with RAAS blockers demonstrated the greatest efficacy in middle-aged patients and in those with the hyperreninemic type of hypertension, while in early postmenopause, valsartan has an advantage over perindopril in achieving regression of LV hypertrophy. A limitation of the study is the relatively short follow-up period (6 months) and the size of the subgroups for comparative analysis of the two drugs.

  • Experimental radiological study on the readiness for real-world clinical application of an artificial intelligence-based program in dentistry

    by K.SH. Oisieva, T.N. Trofimova, V.N. Trezubov, V.R. Veber, R.A. Rozov

    Background. Artificial intelligence (AI) is rapidly evolving and gaining applications in various fields of medicine, including dentistry. In particular, AI systems for analyzing radiological data hold the potential to enhance diagnostic accuracy and efficiency. However, challenges such as compliance with national regulatory standards and the adaptation of AI technologies to clinical practices in the Russian Federation remain significant obstacles. Aims. To evaluate the readiness of AI for real-world clinical application in dentistry in the Russian Federation by comparing the performance of the Diagnocat system with experienced dentists in the interpretation of radiological data. Materials and methods. The study included 100 radiological examinations (CBCT), each corresponding to a unique patient (55 women, 45 men; mean age 42.9±12.1 years). The evaluated parameters included the frequency of diagnostic errors, diagnostic accuracy (e.g., caries, periodontal diseases), and the average time required for data analysis. To assess the statistical significance of differences, the χ² test was applied. The results obtained using Diagnocat were verified and compared with those of clinicians, as confirmed by independent experts. Results. Diagnocat demonstrated no errors in the anterior region and fewer errors in the posterior region compared to dentists (4.86% vs. 7.29%). Diagnocat’s average analysis time was significantly shorter (4.18 minutes) compared to that of dentists (25.05 minutes). While Diagnocat showed high accuracy, some limitations were identified, including difficulties in interpreting complex anatomical structures and pathology severity. Conclusions. Diagnocat shows significant potential for integration into clinical dentistry in the Russian Federation, offering advantages in speed and accuracy under high workload conditions. However, further algorithm refinements and adaptations to Russian medical standards are necessary. The study highlights the value of combining AI capabilities with the clinical expertise of dentists to achieve optimal diagnostic outcomes.

  • Multi-omics of chronic obstructive pulmonary disease: from genetic and metabolomic disorders to personalized medicine

    by L. Y. Nikitina, S. V. Buikin, V. R. Weber, M. Z. Gasanov, S. N. Avdeev

    This review is devoted to the modern understanding of the genetic and metabolomic basis of development, features of the course and therapy of chronic obstructive pulmonary disease, one of the leading causes of morbidity and mortality in the world. It analyzes candidate disease genes, results of genome-wide association studies, and metabolomic changes in COPD. It describes methods for metabolomic profiling and integrative approaches to using this data in the diagnosis and treatment of COPD.

  • EFFECT OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKERS ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION: VALSARTAN AND PERINDOPRIL THERAPY

    by Veronika Alekseevna Pavlova, Viktor Robertovich Veber, Svetlana Viktorovna Zhmaylova

    Arterial hypertension (AH) often leads to left ventricular (LV) remodeling, increasing cardiovascular risk. The role of renin-angiotensin-aldosterone system (RAAS) blockers in the regression of LV pathological changes requires further clarification. Objective: The aim of the study is to evaluate the effect of valsartan and perindopril on the dynamics of LV geometry in patients with newly diagnosed arterial hypertension. Materials and Methods. The study included 44 patients with stage 2 arterial hypertension without chronic diseases that could cause cardiac remodeling. All participants underwent echocardiography before treatment and 6 months after antihypertensive therapy, provided that the target blood pressure level was achieved. To assess the type of remodeling, LV myocardial mass index (LVMI) and LV relative wall thickness (RWT) were determined. Patients were divided into 2 groups: those taking perindopril (n=22) and those taking valsartan (n=22). Statistical processing was performed using the paired Student's t-test (p≤0.05). Results. Initially, concentric LV changes predominated: left ventricular concentric remodeling (LVCR) – 47 %, left ventricular concentric hypertrophy (LVCH) – 37 %. During valsartan therapy, LVCH transformed into LVCR in 50 % of patients with LVCH. Moreover, normalization of LV geometry was observed in 40 % of patients with LVCR. In the perindopril group, transition from LVCH to LVCR was observed in 38 % of patients. However, LVCR transformed to normal left ventricular geometry (NLVG) only in 10 % of patients. LVMI and LV RWT dynamics were statistically significant (p˂0.05). Conclusion. RAAS blockers promote regression of LV hypertrophy, but valsartan is presumably superior to perindopril in efficacy in LV concentric remodeling. The results of the study confirm the advisability of a differentiated approach to the choice of RAAS blockers depending on the type of LV remodeling.

  • Modern aspects to the management of pregnant women with chronic hypertension

    by Viktor R. Veber, Mitkhat Z. Gasanov, Vladislav S. Chulkov, Elena E. Minina, Ekaterina S. Nikolenko, Гасанов Митхат Зульфугар-Оглы

    Women with chronic hypertension (CH) are at risk of various adverse fetal/neonatal outcomes, some of which can be mitigated by appropriate pregnancy management. The risk of complications in women with CH increases with hypertension severity and organ damage. With an increase in the relative risk of these complications, the absolute risk of serious damage to target organs (heart, kidneys, brain) remains low in the absence of preeclampsia or uncontrolled hypertension. Careful monitoring of blood pressure, including the use of home monitoring of the pregnant woman herself, allows minimizing the use of medications, especially in the first trimester, according to physiological changes in blood pressure in the second and third trimesters of pregnancy and the start of antihypertensive drugs ≥140/90 mmHg. There is no doubt that antihypertensive therapy has benefits for women with CH. However, it should be remembered that the long-term goals for treating hypertension in adults fundamentally differ from those for treating hypertension in the short term. The general principle is to gradually reduce blood pressure to avoid a significant decrease in blood flow in the uteroplacental bloodstream. The choice of an antihypertensive drug depends on the safety of the drug, the degree of increase in blood pressure, the availability of drugs, the doctor's experience, as well as side effects and contraindications. The key to managing women with CH is pre-pregnancy counseling about pregnancy risks and possible interventions to minimize these risks. This review systematizes national and international approaches for the management of pregnant women with CH using evidence-based medicine. Modern recommendations should become the basis for personalized management and treatment of pregnant women with CH.


  • Age-related changes in blood renin levels in healthy individuals and patients with arterial hypertension

    by Yaroslav-the-Wise Novgorod State University, V. R. Veber, V. A. Pavlova, Yaroslav-the-Wise Novgorod State University; Pskov State University, A. A. Pavlova, M. M. Mamontova

    The article presents the results of a study on the age-related dynamics of plasma renin levels in healthy individuals and patients with arterial hypertension, including both men and women in different age groups: young adults (25–44 years), middle-aged adults (45–59 years), and older adults (60 years and older). The study revealed the following pattern: with age, healthy men and women showed a progressive and significant decrease in plasma renin levels compared to the young adult group. In contrast, patients with arterial hypertension demonstrated a significant increase in renin levels with age. The age-related trend in plasma renin levels was similar in men and women but was more pronounced in men.

  • Relevance of left and right ventriculars hypertrophy to the cause of death in arterial hypertension (according to autopsy data)

    by Astana Medical University, A. S. Kerimkulova, V. R. Veber, Yaroslav-the-Wise Novgorod State University, L. G. Proshina, S. V. Zhmailova

    The authors studied data from autopsy reports of 643 individuals who had suffered from arterial hypertension during their lifetime. Cases that could be another cause of left or right ventricular hypertrophy were excluded from the study. Hypertrophy of the left and right ventricular walls was conditionally divided into two degrees: moderate left ventricular hypertrophy – 1st degree (1.3–2.0 cm), pronounced – 2nd degree (2.1 cm and more); moderate right ventricular hypertrophy – 1st degree (0.4–0.6 cm), pronounced – 2nd degree (0.7 cm and more). According to autopsy findings, arterial hypertension leads to left ventricular hypertrophy in all cases, with moderate hypertrophy being detected slightly more frequently than marked hypertrophy. Right ventricular hypertrophy was not detected in only 13% of cases, with severe hypertrophy predominating over moderate hypertrophy. The most frequent causes of death in arterial hypertension are acute heart failure (60.4%) and cerebral hemorrhage (37.2%). Myocardial infarction was detected in 1.2% of cases, other causes also in 1.2% of cases. Myocardial mass and degree of hypertrophy of both ventricles of the heart directly influence the causes of death in arterial hypertension. In degree 2 left ventricular hypertrophy, cardiac death develops 3.7 times more often in men and 3.0 times more often in women compared with cerebral causes. In 2nd degree right ventricular hypertrophy, cardiac cause of death compared to cerebral cause predominates 2.96 times more often in men and 2.37 times more often in women. Cerebral cause of death significantly prevails over cardiac cause of death in moderate hypertrophy of both left and right ventricles of the heart.

  • Frequency of hypertrophy development in the right ventricle with arterial hypertension according to post-mortem examination data

    by Yaroslav-the-Wise Novgorod State University, V. R. Veber, A. S. Kerimkulova, Astana Medical University, S. V. Zhmailova, L. G. Proshina, E. E. Rumyantsev, I. A. Ataev

    We have analyzed 674 autopsy reports of patients who died suddenly within 24 hours (myocardial infarction, stroke) and who suffered from arterial hypertension (AH) during their lifetime. There were 388 men (60,3%) and 255 women (39,7%). The study excluded cases that could have been caused by another cause of development (left ventricular hypertrophy, right ventricular hypertrophy) of LVH or RVH (defects, chronic obstructive pulmonary disease, etc.). The subjects were divided into 7 age groups, with a 10-year step, starting with the age category up to 29 years old and ending with the older age group of 80 years and older. Heart size was determined with a measuring metal ruler. Ventricular muscle thickness was determined on transverse incisions made midway between the apex of the heart and the valve ring. The normal thickness of the left ventricle wall (excluding papillary muscles) was taken to be 0,7-1,2 cm, and the right ventricle wall thickness was 0,2-0,3 cm. The authors concluded that right ventricular hypertrophy is a common manifestation of hypertension; there are gender differences in the incidence and severity of RVH. A close relationship was found between the hypertrophies of both ventricles of the heart. In the presence of LV hypertrophy, RV hypertrophy develops in a significant number of cases (87%).

  • DIAGNOSTIC SIGNIFICANCE OF LABORATORY STUDY OF RENIN LEVELS IN BLOOD IN PATIENTS WITH HYPERTENSION

    by V. A. Pavlova, Yaroslav-the-Wise Novgorod State University, A. A. Pavlova, V. R. Weber, S. V. Zhmaylova

    The article presents the results of studying blood renin in arterial hypertension in men and women in two age groups: young and middle-aged. Renin was determined by examination of venous blood by enzymelinked immunosorbent assay. In a study of a group of 80 patients: 40 women and 40 men, it was found that the normorenin type of arterial hypertension predominates at young age: 95% in men and 90% in women. In the course of the study, the following feature was revealed: the incidence of high-renin arterial hypertension increases with age. In middle-aged men, high-renin arterial hypertension predominates (55%), while in middleaged women, the normorenin type of arterial hypertension predominates (60%).

  • Open Access

    Maxillary mucous membrane and bone regeneration after tooth extraction. The use of an autograft. Experimental study

    by N. V. Prozorova, R. A. Fadeev, V. R. Veber, M. R. Fadeeva, I. V. Prozorova, N. I. Enukashvily, V. E. Karev, A. V. Gasporevich, V. A. Gubarev

    Relevance. The issue of oral mucosa and bone tissue restoration after tooth extraction and other dental interventions determines the study's relevance. The article presents experimental study results of regeneration processes in the animal oral mucosa and bone tissue wound surface during two operations: tooth extraction without bone structure and material grafting and tooth extraction with autologous dental tissue grafting.Material and methods. The study included 24 laboratory male Wistar rats divided into two groups. The animals of the main group underwent tooth extraction followed by simultaneous autologous tissue grafting into the extracted tooth socket. The autograft consisted of the tissues of a particulated tooth previously removed from the subject. Animals of the control group underwent tooth extraction without bone structures and material grafting.Results. On day 21, all study groups showed complete oral mucosa regeneration in the extracted tooth area. After 1.5 months of control group observation, the socket floor was filled with mature granulation tissue, transforming into fibrous tissue. The main study group demonstrated bone formation by autograft replacement in the coarse fibrous tissue growth thickness. After three months of observation, the control group showed bone atrophy at the extracted tooth site. In the main study group, there was newly formed bone tissue, which had replaced the autograft.Conclusion. The conducted experimental study demonstrates that autologous particulated dental tissue grafting leads to active new bone formation, which the histology results confirmed in 21 days, 1.5 and 3 months of followup observation.